Stock Report

Supriya Lifescience Ltd Q3 FY2025 PAT up at Rs. 46.78 crores

Posted On : 2025-01-27 20:24:14( TIMEZONE : IST )

Supriya Lifescience Limited has reported Standalone financial results for the period ended December 31, 2024.

Financial Results (Q3 FY2025) - QoQ Comparison

The company has reported total income of Rs. 187.745 crores during the period ended December 31, 2024 as compared to Rs. 168.620 crores during the period ended September 30, 2024.

The company has posted net profit / (loss) of Rs. 46.783 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs. 46.149 crores for the period ended September 30, 2024.

The company has reported EPS of Rs. 5.82 for the period ended December 31, 2024 as compared to Rs. 5.71 for the period ended September 30, 2024.

Financials	Q3 FY2025	Q2 FY2025	% Change
Total Income	₹ 187.745 crs	₹168.620 crs	11.34%
Net Profit	₹46.783 crs	₹46.149 crs	1.37%
EPS	₹5.82	₹5.71	1.93%

Financial Results (Q3 FY2025) - YoY Comparison

The company has reported total income of Rs. 187.745 crores during the period ended December 31, 2024 as compared to Rs.143.139 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.46.783 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs.29.787 crores for the period ended December 31, 2023.

The company has reported EPS of Rs.5.82 for the period ended December 31, 2024 as compared to Rs.3.70 for the period ended December 31, 2023.

Financials	Q3 FY2025	Q3 FY2024	% Change
Total Income	₹ 187.745 crs	₹143.139 crs	31.16%
Net Profit	₹46.783 crs	₹29.787 crs	57.06%
EPS	₹5.82	₹3.70	57.30%

Financial Results (9 Months Ended FY2025) - YoY Comparison

The company has reported total income of Rs.519.216 crores during the 9 Months period ended December 31, 2024 as compared to Rs.420.639 crores during the 9 Months period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.137.576 crores for the 9 Months period ended December 31, 2024 as against net profit / (loss) of Rs.82.182 crores for the 9 Months period ended December 31, 2023.

The company has reported EPS of Rs.17.07 for the 9 Months period ended December 31, 2024 as compared to Rs.10.21 for the 9 Months period ended December 31, 2023.

Financials	9 Months Ended FY2025	9 Months Ended FY2024	% Change
Total Income	₹519.216 crs	₹420.639 crs	23.44%
Net Profit	₹137.576 crs	₹82.182 crs	67.40%
EPS	₹17.07	₹10.21	67.19%

Shares of Supriya Lifescience Limited was last trading in BSE at Rs. 700.80 as compared to the previous close of Rs. 729.45. The total number of shares traded during the day was 24237 in over 1518 trades.

The stock hit an intraday high of Rs. 745.95 and intraday low of 680.00. The net turnover during the day was Rs. 17395122.00.